174 related articles for article (PubMed ID: 4814678)
1. [Molecular and cellular bases of cytostatic therapy].
Schindler R
Schweiz Med Wochenschr; 1974 Feb; 104(8):271-4. PubMed ID: 4814678
[No Abstract] [Full Text] [Related]
2. [New approach to the treatment of malignant diseases using cytostatic drugs. (Comprehensive review)].
Klener P
Vnitr Lek; 1974 May; 20(5):476-84. PubMed ID: 4602412
[No Abstract] [Full Text] [Related]
3. Biological and biochemical effects of chartreusin on mammalian cells.
Li LH; Clark TD; Murch LL; Wooden JM; Pschigoda LM; Krueger WC
Cancer Res; 1978 Sep; 38(9):3012-8. PubMed ID: 567097
[No Abstract] [Full Text] [Related]
4. Cytokinetic and biochemical effects of sangivamycin in human colon carcinoma cells in culture.
Glazer RI; Hartman KD
Mol Pharmacol; 1981 Nov; 20(3):657-61. PubMed ID: 7329408
[No Abstract] [Full Text] [Related]
5. Lethal effect of adriamycin on the division cycle of HeLa cells.
Kim SH; Kim JH
Cancer Res; 1972 Feb; 32(2):323-5. PubMed ID: 5058189
[No Abstract] [Full Text] [Related]
6. Effect of cytostatic drugs on the kinetics of leukemic blast cells in man.
Killmann SA
Schweiz Med Wochenschr; 1974 Feb; 104(8):278-84. PubMed ID: 4814680
[No Abstract] [Full Text] [Related]
7. Antineoplastic and immunosuppressive drugs. I. Biochemical and clinical pharmacological considerations.
Chalmers AH; Burgoyne LA; Murray AW
Drugs; 1972; 3(3):227-53. PubMed ID: 4561638
[No Abstract] [Full Text] [Related]
8. [Anticancer drugs and pharmacologic actions].
Ogawa M
Nihon Rinsho; 1997 May; 55(5):1017-23. PubMed ID: 9155146
[TBL] [Abstract][Full Text] [Related]
9. Modes of action of phleomycin, bleomycin and formycin on HeLa S3 cells in synchronized culture.
Kunimoto T; Hori M; Umezawa H
J Antibiot (Tokyo); 1967 Sep; 20(5):277-81. PubMed ID: 5630770
[No Abstract] [Full Text] [Related]
10. Differential inhibition of DNA and RNA synthesis by neocarzinostatin in cultured Burkitt lymphoma cells.
Kawai Y; Katoh A
J Natl Cancer Inst; 1972 May; 48(5):1535-8. PubMed ID: 5030963
[No Abstract] [Full Text] [Related]
11. Comparative study of early effects of epipodophyllotoxin derivatives and other cytostatic agents on mastocytoma cultures.
Grieder A; Maurer R; Stähelin H
Cancer Res; 1977 Sep; 37(9):2998-3005. PubMed ID: 69488
[No Abstract] [Full Text] [Related]
12. The dependence of DNA and RNA synthesis on protein synthesis in asparaginase-treated lymphoma cells.
Ellem KA; Fabrizio AM; Jackson L
Cancer Res; 1970 Feb; 30(2):515-27. PubMed ID: 5458976
[No Abstract] [Full Text] [Related]
13. CC-1065 (NSC 298223), a most potent antitumor agent: kinetics of inhibition of growth, DNA synthesis, and cell survival.
Bhuyan BK; Newell KA; Crampton SL; Von Hoff DD
Cancer Res; 1982 Sep; 42(9):3532-7. PubMed ID: 7105029
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of a protein complex from Viscum album on fibroblasts and HeLa cells.
Klamerth O; Vester F; Kellner G
Hoppe Seylers Z Physiol Chem; 1968 Jun; 349(6):863-4. PubMed ID: 5722830
[No Abstract] [Full Text] [Related]
15. A comparison of the rate of recovery from inhibition of RNA synthesis in mouse liver and transplantable glioma.
Yarbro JW; Kennedy BJ
Cancer Res; 1967 Oct; 27(10):1779-82. PubMed ID: 6064957
[No Abstract] [Full Text] [Related]
16. [Chemotherapy of solid tumors. Epitheliomas and sarcomas of non-hematopoietic organs].
Clavel B
Sem Hop; 1971 May; 47(22):1439-48. PubMed ID: 4326096
[No Abstract] [Full Text] [Related]
17. Biochemical rationales for the selection of combinations of chemotherapeutic agents.
Bono VH
Cancer Chemother Rep 2; 1974 Mar; 4(1):131-6. PubMed ID: 4826492
[No Abstract] [Full Text] [Related]
18. [Control of DNA synthesis in neoplastic tissue using bleomycin].
Müller WE; Yamazaki Z; Zahn RK
Hoppe Seylers Z Physiol Chem; 1972 Oct; 353(10):1551. PubMed ID: 4119464
[No Abstract] [Full Text] [Related]
19. The action of streptozotocin on mammalian cells.
Bhuyan BK
Cancer Res; 1970 Jul; 30(7):2017-23. PubMed ID: 5456086
[No Abstract] [Full Text] [Related]
20. Antileukemic activity of synthetic daunomycinone derivatives bearing modifications in the glycosidic moiety.
Perchellet EM; Sperfslage BJ; McIlvain CJ; Aligiannis N; Pouli N; Marakos P; Skaltsounis AL; Perchellet JP
Anticancer Res; 2001; 21(6A):3957-67. PubMed ID: 11911277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
